Legal & General Group PLC Medpace Holdings, Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 58,455 shares of MEDP stock, worth $18.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,455
Previous 58,455 -0.0%
Holding current value
$18.4 Million
Previous $19.5 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$320.58 - $457.29 $2.08 Million - $2.97 Million
6,494 Added 12.5%
58,455 $19.5 Million
Q2 2024

Aug 14, 2024
BUY
$372.0 - $424.34 $616,404 - $703,131
1,657 Added 3.29%
51,961 $21.4 Million
Q1 2024

May 14, 2024
BUY
$284.87 - $413.31 $231,314 - $335,607
812 Added 1.64%
50,304 $20.3 Million
Q4 2023

Feb 15, 2024
SELL
$227.52 - $312.68 $416,361 - $572,204
-1,830 Reduced 3.57%
49,492 $15.2 Million
Q3 2023

Nov 14, 2023
SELL
$233.98 - $281.67 $900,823 - $1.08 Million
-3,850 Reduced 6.98%
51,322 $12.4 Million
Q2 2023

Aug 14, 2023
BUY
$187.26 - $240.17 $1.62 Million - $2.07 Million
8,626 Added 18.53%
55,172 $13.3 Million
Q1 2023

May 15, 2023
SELL
$174.31 - $239.52 $539,315 - $741,074
-3,094 Reduced 6.23%
46,546 $8.75 Million
Q4 2022

Feb 14, 2023
BUY
$153.06 - $226.57 $273,365 - $404,654
1,786 Added 3.73%
49,640 $10.5 Million
Q3 2022

Nov 14, 2022
SELL
$145.13 - $182.49 $694,592 - $873,397
-4,786 Reduced 9.09%
47,854 $7.52 Million
Q2 2022

Aug 22, 2022
SELL
$130.2 - $168.03 $208,840 - $269,520
-1,604 Reduced 2.96%
52,640 $7.88 Million
Q1 2022

May 16, 2022
BUY
$138.87 - $214.31 $72,906 - $112,512
525 Added 0.98%
54,244 $8.87 Million
Q4 2021

Feb 14, 2022
SELL
$182.74 - $227.9 $190,049 - $237,016
-1,040 Reduced 1.9%
53,719 $11.7 Million
Q3 2021

Nov 15, 2021
BUY
$170.18 - $198.21 $872,683 - $1.02 Million
5,128 Added 10.33%
54,759 $10.4 Million
Q2 2021

Aug 12, 2021
SELL
$158.62 - $194.3 $1.35 Million - $1.66 Million
-8,518 Reduced 14.65%
49,631 $8.77 Million
Q1 2021

May 17, 2021
BUY
$132.02 - $168.26 $1.3 Million - $1.65 Million
9,814 Added 20.3%
58,149 $9.54 Million
Q4 2020

Feb 12, 2021
BUY
$109.38 - $149.19 $610,340 - $832,480
5,580 Added 13.05%
48,335 $6.73 Million
Q3 2020

Nov 13, 2020
SELL
$92.95 - $130.61 $4.26 Million - $5.99 Million
-45,877 Reduced 51.76%
42,755 $4.78 Million
Q2 2020

Aug 14, 2020
BUY
$68.08 - $95.68 $506,515 - $711,859
7,440 Added 9.16%
88,632 $8.25 Million
Q1 2020

May 14, 2020
BUY
$61.71 - $101.95 $99,044 - $163,629
1,605 Added 2.02%
81,192 $5.97 Million
Q4 2019

Feb 13, 2020
BUY
$70.08 - $84.64 $587,410 - $709,452
8,382 Added 11.77%
79,587 $6.69 Million
Q3 2019

Nov 13, 2019
BUY
$62.38 - $85.89 $120,830 - $166,368
1,937 Added 2.8%
71,205 $5.98 Million
Q2 2019

Aug 14, 2019
BUY
$53.64 - $65.42 $79,923 - $97,475
1,490 Added 2.2%
69,268 $4.53 Million
Q1 2019

May 15, 2019
BUY
$49.38 - $70.58 $2.21 Million - $3.15 Million
44,676 Added 193.39%
67,778 $4 Million
Q4 2018

Feb 15, 2019
BUY
$46.97 - $63.98 $923,712 - $1.26 Million
19,666 Added 572.35%
23,102 $1.2 Million
Q3 2018

Nov 20, 2018
BUY
$43.25 - $63.74 $65,394 - $96,374
1,512 Added 78.59%
3,436 $206,000
Q2 2018

Aug 10, 2018
BUY
$34.03 - $45.46 $10,923 - $14,592
321 Added 20.02%
1,924 $82,000
Q1 2018

May 17, 2018
SELL
$32.03 - $39.05 $11,722 - $14,292
-366 Reduced 18.59%
1,603 $56,000
Q4 2017

Feb 13, 2018
BUY
$32.46 - $38.31 $63,913 - $75,432
1,969
1,969 $72,000

Others Institutions Holding MEDP

# of Institutions
617
Shares Held
25.1M
Call Options Held
42.8K
Put Options Held
207K
View Full List

About Medpace Holdings, Inc.

MEDP Quotes by TradingView
  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $9.8B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email